Loading Dose of Ceftazidime Needs to Be Increased in Critically Ill Patients: A Retrospective Study to Evaluate Recommended Loading Dose with Pharmacokinetic Modelling
Open Access
- 11 August 2024
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 13 (8) , 756
Abstract
To rapidly achieve ceftazidime target concentrations, a 2 g loading dose (LD) is recommended before continuous infusion, but its adequacy in critically ill patients, given their unique pharmacokinetics, needs investigation. This study included patients from six ICUs in Saint-Etienne and Paris, France, who received continuous ceftazidime infusion with plasma concentration measurements. Using MONOLIX and R, a pharmacokinetic (PK) model was developed, and the literature on ICU patient PK models was reviewed. Simulations calculated the LD needed to reach a 60 mg/L target concentration and assessed ceftazidime exposure for various regimens. Among 86 patients with 223 samples, ceftazidime PK was best described by a one-compartment model with glomerular filtration rate explaining clearance variability. Typical clearance and volume of distribution were 4.45 L/h and 88 L, respectively. The literature median volume of distribution was 37.2 L. Simulations indicated that an LD higher than 2 g was needed to achieve 60 mg/L in 80% of patients, with a median LD of 4.9 g. Our model showed a 4 g LD followed by 6 g/day infusion reached effective concentrations within 1 h, while a 2 g LD caused an 18 h delay in achieving target steady state.Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- Towards optimization of ceftazidime dosing in obese ICU patients: the end of the ‘one-size-fits-all’ approach?Journal of Antimicrobial Chemotherapy, 2023
- Ceftazidime dosing in obese patients: is it time for more?Expert Opinion on Drug Metabolism & Toxicology, 2022
- Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult PatientsClinical Pharmacokinetics, 2022
- Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patientsJournal of Antimicrobial Chemotherapy, 2020
- What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modellingInternational Journal of Antimicrobial Agents, 2020
- Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 2019
- Population pharmacokinetics and dosing simulations of ceftazidime in critically ill patients receiving sustained low-efficiency dialysisJournal of Antimicrobial Chemotherapy, 2017
- Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug DevelopmentCPT: Pharmacometrics & Systems Pharmacology, 2012
- Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacinClinical Biochemistry, 2012
- Population pharmacokinetics of ceftazidime in burn patientsBritish Journal of Clinical Pharmacology, 2003